Cefazolin Sodium (Page 8 of 8)

PRINCIPAL DISPLAY PANEL — 2 g Cefazolin

Cefazolin for Injection USP and Dextrose Injection USP

2g*

REF 3105-11
NDC 0264-3105-11

DUPLEX® CONTAINER

50 mL

Use only after mixing contents of both chambers.
For IV Use Only Iso-osmotic Single Dose Sterile/Nonpyrogenic

* Contains Cefazolin Sodium USP equivalent to 2 g cefazolin.

Reconstitution: Hold container with set port in a downward direction and fold the diluent chamber just below the solution meniscus. To activate seal, squeeze folded diluent chamber until seal between diluent and drug chamber opens, releasing diluent into drug chamber. Agitate the reconstituted solution until the drug powder is completely dissolved. Fold the container a second time and squeeze until seal between drug chamber and set port opens.

After reconstitution each 50 mL single dose unit contains: Cefazolin for Injection USP (equivalent to 2 g cefazolin) with approx. 1.5 g (3.0% w/v) Hydrous Dextrose USP in Water for Injection USP. Sodium content is 48 mg/g of cefazolin sodium.
Approximate osmolality: 290 mOsmol/kg

Prior to Reconstitution: Store at 20-25°C (68-77°F). Excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Use only if container and seals are intact. Do not peel foil strip until ready for use. After foil strip removal, product must be used within 7 days, but not beyond the labeled expiration date. Protect from light after removal of foil strip.

After Reconstitution: Use only if prepared solution is clear and free from particulate matter. Use within 24 hours if stored at room temperature or within 7 days if stored under refrigeration. Do not use in a series connection. Do not introduce additives into this container. Prior to administration check for minute leaks by squeezing container firmly. If leaks are found, discard container and solution as sterility may be impaired. Do not freeze.

Not made with natural rubber latex, PVC or DEHP.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524

Rx only

Prepared in USA. API from USA and Italy.

LD-200-4
Y37-002-542

EXP
LOT

PEEL HERE

Drug Chamber
Discard unit if foil strip is damaged. Peel foil strip only when ready for use. Visually inspect drug prior to reconstitution.
See package insert for complete directions for reconstitution and administration.LD-336-1 X27-001-485

3105-11 Container Label
(click image for full-size original)
Drug Chamber Label
(click image for full-size original)
CEFAZOLIN SODIUM cefazolin sodium solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0264-3103
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFAZOLIN SODIUM (CEFAZOLIN) CEFAZOLIN 1 g in 50 mL
Inactive Ingredients
Ingredient Name Strength
DEXTROSE MONOHYDRATE 2 g in 50 mL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0264-3103-11 24 CONTAINER in 1 CASE contains a CONTAINER
1 50 mL in 1 CONTAINER This package is contained within the CASE (0264-3103-11)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA050779 07/27/2000
CEFAZOLIN SODIUM cefazolin sodium solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0264-3105
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFAZOLIN SODIUM (CEFAZOLIN) CEFAZOLIN 2 g in 50 mL
Inactive Ingredients
Ingredient Name Strength
DEXTROSE MONOHYDRATE 1.5 g in 50 mL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0264-3105-11 24 CONTAINER in 1 CASE contains a CONTAINER
1 50 mL in 1 CONTAINER This package is contained within the CASE (0264-3105-11)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA050779 01/13/2012
Labeler — B. Braun Medical Inc. (002397347)

Revised: 07/2021 B. Braun Medical Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.